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Various mitochondrial inhibitors are tested in neuroblastoma cells. Their effects on the mit-proteins and 
some cytoskeletal proteins are compared to those of CCA, a differentiation inducer. This comparison 
favours the hypothesis that the primary effect of CCA induction is an alteration of the electrochemical 
gradient. 
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1. INTRODUCTION 
Neuroblastoma clones are routinely considered 
as a convenient model for studying genetic expres- 
sion during terminal differentiation of neurons 
[l-4]. In previous studies we tested, in murine 
neuroblastoma cells, the inducing effects on 
neurogenesis of various pharmacologically active 
substances known for their antianoxic effect on rat 
brain, One of them, the compound CCA, is a po- 
tent inducer, causing ultimate modifications of the 
membrane-bound and cytoskeletal proteins [5-71. 
Prior to any visible change in cell growth and mor- 
phology of the developing neuroblastoma, CCA 
promotes a significant increase in cellular ac- 
cumulation of the complex between phosphoryl- 
ated deoxy[14C]glucose and hexose phosphate 
isomerase [8]. In [9], this accumulation is said to 
reflect glucose utilization. 
examine in particular the fate of mitochondrial 
(mit)-proteins during the course of neuroblastoma 
differentiation. We selected 3 major mit-proteins 
(4, 5 and Cl), which could act as major sites for a 
developmentally controlled modification since 
methionine incorporation into these markers in- 
creases during the course of CCA-induced 
neurogenesis [ 10,111. This result supports the view 
that the inducing effect of CCA can be correlated 
to mitochondrial metabolism. In an attempt to 
elucidate the molecular mechanisms underlying 
this correlation, we examined the effects of various 
mitochondrial inhibitors on neuroblastoma cells. 
Here, we compare the effects of these inhibitors to 
those of CCA on the mit-proteins and some 
cytoskeletal and insoluble proteins which exhibit 
changes during CCA treatment. 
Consequently, our attention was drawn to a 
possible general relationship between mitochon- 
drial function and neurogenesis, and that led us to 
2. MATERIALS AND METHODS 
2.1. Cell culture 
* To whom correspondence should be addressed 
Abbreviations: CCA, I-methylcyclohexane carboxylic 
acid; DNP, dinitrophenol; mit-protein, mitochondrial 
protein 
We used the NlE115 clone from mouse 
neuroblastoma C1300. The conditions of cultures 
have been described [121. The cells were grown at- 
tached to a culture dish. In this situation, clone 
NlE115 extends neurites when CCA is added to 
the serum-containing medium. 
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2.2. Drug treatment 
2.2.1. CCA-treated cultures 
The cells were maintained for 4 days in the 
presence of 0.1% CCA, then kept for the last 6 h 
with labeling in the presence of CCA. Cultures 
were changed with fresh medium every 24 h. 
2.2.2. Antimitochondrial drug treatment 
The cells were maintained for 4 days with 
various antimitochondrial agents (5 ,uM nonactin, 
1 mM dinitrophenol (DNP), 0.6pM oligomycin, 
or 1 mM NaN3) added to the serum-containing 
medium. 
2.3. Protein labeling and cell extract preparation 
Control cells growing in a serum-containing 
medium, CCA-differentiated cells and cells treated 
with an antimitochondrial drug were labeled for 
6 h with [35S]methionine (50,~Ki/ml medium) 
prior to harvesting. The 10 cm diameter dishes 
were inoculated so that they contained 2.5 x lo6 
cells at the time of harvesting. Cell extracts were 
prepared and analysed on two-dimensional elec- 
trophoresis as in [5]. 
2.4. Preparation of mit-proteins 
Purification of mit-proteins was achieved as in 
[13]. Cells prelabeled with [35S]methionine were 
homogenized in 0.25 M sucrose/O.3 mM EDTA 
(pH 7.4) and spun at 600 x g for 10 min. The 
supernatant was centrifuged at 100000 x g for 
10 min, and the resulting pellet was washed twice. 
The last pellet was resuspended in 50% (w/w) 
sucrose/O.3 mM EDTA and layered under a step 
gradient of 44.5 and 41% sucrose. This was cen- 
trifuged for 2 h at 45000 rpm in a Beckman type 
50 rotor. The material banding between 41 and 
44.5% sucrose was diluted into 0.25 M 
sucrose/O.3 M EDTA, centrifuged at 10000 x g 
for 10 min and the resulting pellet was dissolved 
for protein analysis in 8 M urea/20% Nonidet 
P-40/2% ampholines (LKB, 3.5-10/l% 
mercaptoethanol. 
Fig. 1. Areas from two-dimensional gels loaded with NlE-115 neuroblastoma extracts. Cells were labeled for 6 h prior 
to harvesting; 7 x lo5 cpm corresponding to 35S-labeled proteins were loaded on each gel. (a) Control culture growing 
in a complete medium. (b) Nonactin-treated cultures. Protein JLr is detectable in the latter culture conditions. act, actin; 
(or, cur-isotubulin; cyz, cuz-isotubulin; ,8, &isotubulin; Vi, vimentin; 4, mit-protein 4; 5, mit-protein 5; CI, mit-protein 
Cr; M, protein M; Y, protein Y; Z, protein Z. 
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3. RESULTS 
Various antimitochondrial agents have been 
tested: dinitrophenol (the classical uncoupler), 
oligomycin (a mitochondrial ATPase inhibitor), 
nonactin (a K+ ionophore), and NaN3 (a 
cytochrome inhibitor). NaN3 directly blocks the 
electronic flow while the other 3 specific inhibitors 
alter coupling between the oxidations and ATP 
synthesis. 
cytoskeletal and associated proteins occur during 
neuroblastoma development. The sequence of 
these events has been described [7]. In addition to 
their effects on protein synthesis, antimitochon- 
drial agents like CCA block cell division. 
The effects of CCA and the antimitochondrial 
agents are shown in table 1: 
The proteins studied are shown in fig. 1. The first 
group is composed of the mit-proteins 4, 5 and Cl 
(described in [ 10,111) and of the insoluble proteins 
M and Z which copurify with the mitochondria. 
The synthesis of these proteins is enhanced when 
neuroblastoma differentiation is induced by CCA. 
A second neuronal group of proteins consists of: 
(i) the cytoskeletal components isotubulins, actin 
and vimentin; (ii) the insoluble protein Y 
characterized in our laboratory as specific of 
neuronal cells from the peripheral nervous system 
[14]; (iii) the Nonidet P40, insoluble protein 
JLr. The latter is detectable after the addition of 
either CCA or antimitochondrial drugs to the 
cultures. Changes in the rates of synthesis of these 
(i) Group I: Methionine incorporation is enhanced 
in all of these proteins after CCA treatment. 
Oligomycin has a similar effect. In contrast, the 
synthesis of mit-proteins 4, 5 and Cr is completely 
inhibited by nonactin and DNP, and strongly 
reduced by NaNs. Differential effects have been 
observed on the insoluble proteins M and Z copuri- 
fying with mit-proteins. The synthesis of Z is not 
altered by antimitochondrial agents, but synthesis 
of M is enhanced in the presence of nonactin or 
DNP. 
(ii) Group II: The insoluble proteins Y and JLr ex- 
hibit the same pattern of variation. Their synthesis 
is strongly enhanced by either CCA or the in- 
hibitors which uncouple oxidations and ATP syn- 
thesis. In contrast, synthesis is reduced or sup- 
pressed by NaN3. Vimentin synthesis is stimulated 
Table 1 
Comparative effects of CCA and of antimitochondrial agents on methionine 
incorporation into proteins from group I and II 
CCA Oligomycin Nonactin Dinitrophenol Sodium azide 
(0.1%) (0.6 PM) (5 PM) (1 mM) (1 mM) 
Group I 
4 1.50 1.53 NS NS 0.36 
5 1.40 1.30 NS NS 0.57 
Cl 1.90 2.60 NS NS 0.49 
Z 2.00 1.20 1.00 1.05 0.90 
M 2.20 2.50 2.00 1.60 0.84 
Group II 
JL1 S S S S NS 
Y 4.00 3.20 2.60 2.60 0.75 
Vi 3.75 1.75 0.70 0.43 0.85 
Actin 0.58 1.25 0.77 0.70 0.88 
ffl 0.57 1 0.94 0.63 0.63 
ff2 1.20 1 0.69 0.67 0.67 
P 0.88 1.20 0.72 0.60 0.53 
The data are expressed relative to the values found in control cultures (cells growing 
in a complete medium) which can be considered as equal to unity. No quantitative data 
are shown for JLi since this protein is not detectable in control cultures. S, 
synthesized; NS, not synthesized 
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by CCA and oligomycin, and reduced by the other 
antimitochondrial drugs. 
Actin and isotubulins are reduced by nonactin, 
DNP and NaN3, but are not significantly modified 
by oligomycin. As shown [5], CCA also reduces 
the synthesis of these proteins except for 
crz-isotubulin. 
4. DISCUSSION 
The electrochemical gradient generated by elec- 
tron transport along the respiratory chain is used 
for ATP synthesis, transport of the substrates 
necessary for respiration, processing of mitochon- 
drial proteins, and ion transport. The an- 
timitochondrial drugs which block (oligomycin), 
discharge (nonactin, DNP) or suppress the elec- 
trochemical gradient (NaN3) cause alterations to 
these functions. 
Here, we have paid particular attention to the 
physiological and molecular effects of the drugs 
within the neuroblastoma cells. All of these agents 
block cell division. This is probably due to ATP 
depletion. 
In contrast, changes in the synthetic rates of mit- 
proteins or cytoskeletal and associated proteins de- 
pend on the type of antimitochondrial agents. 
Therefore, these changes cannot be related just to 
ATP depletion (or arrest of cell division), and thus 
alteration of the electrochemical gradient does not 
affect uniquely mitochondrial functions. This ex- 
tensive analysis allows us to conclude that the elec- 
trochemical gradient strictly controls the proces- 
sing of mit-proteins 4, 5 and Cr and may affect 
significantly most of the cytoskeletal components 
and associated proteins. Consequently, the regula- 
tions depend not only on the aerobic ATP produc- 
tion but also on the ionic repartitions across the 
mitochondrial membrane. 
A comparison of the effects of the an- 
timitochondrial agents and those produced by 
CCA reveals a marked similarity between the po- 
tent neural differentiation inducer and the 
mitochondrial ATPase inhibitor, oligomycin. This 
suggests that a common molecular mechanism 
operates at least at one level: CCA may affect the 
electrochemical gradient, like oiigomycin. This 
hypothesis is supported by oxygraphic measure- 
ments (not shown). However, the similarity does 
not involve all of the proteins studied. Further- 
22 
more, oligomycin is not a neural inducer. We 
postulate that CCA causes an alteration in the elec- 
trochemical gradient and, thereby, promotes 
changes in the ionic environment of the mito- 
chondrion. This change would, in turn, cause a 
rearrangement of the filamentous proteins leading 
to the differentiated state. 
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